Results 81 to 90 of about 17,554 (214)

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study

, 2009
JP Baguet1, R Asmar2, P Valensi3, S Nisse-Durgeat4, JM Mallion11Clinique de Cardiologie, CHU de Grenoble, Grenoble, France; 2Institut CardioVasculaire, Paris, France; 3Service d’Endocrinologie-Diabétologie-Nutrition, CHU Jean Verdier,
JP Baguet, P Valensi, JM Mallion, S Nisse-Durgeat, R Asmar   +4 more
core  

FORMULATION AND EVALUATION OF CANDESARTAN CILEXETIL TRANSDERMAL PRONIOSOMAL GEL

, 2014
The present work deals with the preparation of candesartan cilexetil proniosomal gel by coaservation phase separation method by using different surfactants, cholesterol and soya lecithin in 9:1:9 and 9:2:9 ratios.
pinnika, archana
core   +1 more source

Preformulation of Immediate Release Candesartan Cilexetil Tablets Using Full Factorial Experimental Design

, 2016
This work aimed compatibility and stability studies, five factor and two level (25) full factorial experimental design of immediate release candesartan cilexetil 32 mg tablets.
Guven, Olgun, Capan, Yilmaz, Saracbasi, Osman, Yuce, Meral, Karahan, Sevilay   +4 more
core   +1 more source

Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials

, 2007
Ramzi EL Féghali1, Sophie Nisse-Durgeat2, Roland Asmar11The CardioVascular Institute, Paris, France; 2Laboratoires Takeda, Puteaux, FranceObjective: To study the effect of candesartan cilexetil (CC) in the management of blood pressure (BP) in ...
Asmar, Sophie Nisse-Durgeat, Ramzi EL Féghali, Rol   +3 more
core  

A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension

, 2011
Background: Candesartan is a relatively novel antihypertensive agent of the angiotensin receptor blocker (ARB). Several clinical trials have compared candesartan with losartan in the management of essential hypertension.
null Shan Lin, null Huilan Shi, null Dong Li, null Junya Jia, null Zhenfeng Zheng   +4 more
core   +1 more source

Effect of candesartan on New York Heart Association functional class - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

, 2004
AIMS: To evaluate the effect of the angiotensin receptor blocker candesartan on New York Heart Association (NYHA) functional class in a broad spectrum of patients with chronic heart failure (CHF). METHODS AND RESULTS: Patients in the CHARM Programme with
O'Meara, E., McMurray, J., Michelson, E., Pfeffer, M, Yusuf, S, Swedberg, Karl,, McMurray, J, Swedberg, K, Granger, C, O'Meara, E, Yusuf, S., Young, J. B., Solomon, S, Solomon, S., Olofsson, B, Pfeffer, M., Michelson, E, Olofsson, B., Granger, C., Young, JB   +19 more
core   +1 more source

Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage

, 2019
Background and Purpose: Uncertainty persists over the effects of blood pressure-lowering treatment in acute intracerebral hemorrhage (ICH). We assessed the effects of treatment with candesartan in acute ICH and according to different types of hematoma ...
Berge, E., Berge, T. E., Guo, R., Anderson, C., You, S., Delcourt, C., Jusufovic, M., Bath, P. M., Sandset, E. C., Karlson, Björn W.,   +9 more
core   +1 more source

SIMPLE ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF HYDROCHLOROTHIAZIDE AND CANDESARTAN BY RP-HPLC

, 2017
Objective: To develop a simple, rapid, economic, accurate and precise reverse phase-high performance liquid chromatographic (RP-HPLC) method for the determination of hydrochlorothiazide and candesartan in the pharmaceutical dosage form and to validate as
Madhavi K., M., Navamani, C., Prasanthi, K., Madhavi, Navamani M., Prasanthi C.   +5 more
core   +1 more source

Candesartan [PDF]

, 2020
openaire   +1 more source

Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension

, 2008
Aim. To study candesartan effectiveness and tolerability in essential arterial hypertension (ГАН) and AH associated with chronic renal disease.Material and methods.
G. N. Litonova, O. A. Sivakova, I. E. Chazova, I. P. Kolos, E. V. Blinova, T. A. Sakhnova, N. M. Chikhladze   +6 more
core